Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Comparing Two Soft Tissues Technique on Piriformis Syndrome Patients (MPR-PIR)

25. juni 2026 oppdatert av: Muhammad Muneeb Jafar, University of Faisalabad

Effect of Myofascial Release as Compared to Post Isometric Relaxation in Improving Pain and Lower Extremity Function in Piriformis Syndrome

Piriformis Syndrome is a neuromuscular condition with symptoms of pain, numbness and tingling tracing the route of the sciatic nerve, due to the nerve impingement by the piriformis muscle. Two common manual therapy techniques used to treat musculoskeletal conditions are myofascial release and post-isometric relaxation. The intent of the research is to evaluate the effects of myofascial release (MFR) as compared to post-isometric relaxation (PIR) in improving pain and lower extremity function in piriformis syndrome (LEFS). The study population involved 32 individuals aged between 20 to 50 years who will be randomly assigned to two groups; a group that received MFR and a group that received PIR. Both groups received the baseline treatment for four weeks. The Visual Analog Scale (VAS) will be employed to gauge the amount of pain, while the LEFS was used to measure functional mobility

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

This is Multiple-center, randomized controlled trail. Participants age 20-50 years with diagnosed piriformis syndrome will be referred from neuro physician and orthopedic department of Madina Teaching hospital (MTH) to Physiotherapy ward, Jafar Physiotherapy Clinic and Madina Specilaists Clinic. After informed consent Participants will be randomly assign to one of two parallel groups using a random number generator. Group A (Experimental): Receive MFR 3 sessions per week for total duration 4 weeks. Group B (Active Comparator) receive the PIR 3 sessions per week for total duration 4 weeks. Outcome measures (pain via VAS, functional status via LEFS) are taken at baseline and end of treatment. Data will be analyzed using Spss version 20.

Studietype

Intervensjonell

Registrering (Antatt)

26

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

  • Navn: Dr. Muhammad Ateeb, PhD Public Health
  • Telefonnummer: +923357333383

Studiesteder

  • Pakistan
    • Punjab Province
      • Faisalābad, Punjab Province, Pakistan, 38000
        • The University of Faisalabad

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Positive Lasegue sign
  • Positive FAIR test
  • Grade 1-3 tenderness on palpation of piriformis between sacrum and greater trochanter of femur
  • 4 or more pain intensity on the VAS scale

Exclusion Criteria:

  • Lower extremity injuries including ligament, tendon injuries, muscle strains as well as nerve injuries

    • Systemic diseases including tuberculosis, multiple sclerosis, Parkinson's disease as well as chronic inflammatory conditions
    • Congenital deformities including hip dysplasia, limb length discrepancy, scoliosis and congenital pelvic asymmetry
    • Cognitive issues including dementia, severe depression and severe psychotic disorders
    • Lumbar Radiculopathy
    • SIJ Dysfunction
    • Lower Extremity Fractures
    • Pregnancy
    • Malignancy

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Myofascial release
Myofascial release was then performed with the patient positioned in prone lying. The piriformis muscle was identified. Sustained pressure was applied directly to the trigger point/piriformis muscle for 10-100 seconds while the patient actively moved the affected limb repeatedly from internal to external rotation. Kneading strokes parallel to the muscle fibers were then performed for 5 minutes to promote elongation. This sequence was repeated three times.
Annen: Myofascial Release
Myofascial release is performed with the patient positioned in prone lying. The piriformis muscle was identified. Sustained pressure was applied directly to the trigger point/piriformis muscle for 10-100 seconds while the patient actively moved the affected limb repeatedly from internal to external rotation. Kneading strokes parallel to the muscle fibers were then performed for 5 minutes to promote elongation. This sequence was repeated three times.
Eksperimentell: Post Isometric Relaxation

The patient is in supine and the hip in neutral rotation. The affected hip was passively moved into horizontal adduction until a mild stretch was felt, while the lumbar spine was stabilized. The patient performed a gentle isometric contraction into hip abduction for 7-10 seconds, followed by 2-3 seconds of relaxation. The leg was then moved into further adduction to a new barrier.

This contraction-relaxation-stretch cycle was performed for 3 sets of 5 repetitions.
Annen: Post Isometric Relaxation
Post-isometric relaxation (PIR) is performed with the patient in supine and the hip in neutral rotation. The affected hip was passively moved into horizontal adduction until a mild stretch was felt, while the lumbar spine was stabilized. The patient performed a gentle isometric contraction into hip abduction for 7-10 seconds, followed by 2-3 seconds of relaxation. The leg was then moved into further adduction to a new barrier.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Visual analogue scale
Tidsramme: Baseline and 4 week post intervention
Comparison on effect of pain. The Visual Analog Scale is a self-reported measure of pain intensity. Participants rate their pain on a 10-cm scale ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain."
Baseline and 4 week post intervention

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Lower Extremity Functional Scale
Tidsramme: Baseline and 4 week of post intervention
Comparison on effect of functional outcomes. The Lower Extremity Functional Scale (LEFS) is a self-reported questionnaire used to assess functional status and difficulty performing everyday activities in individuals with lower extremity musculoskeletal conditions. The scale consists of 20 items, each scored from 0 to 4, yielding a total score ranging from 0 to 80.
Baseline and 4 week of post intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

University of Faisalabad

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

30. juni 2026

Primær fullføring (Antatt)

30. august 2026

Studiet fullført (Antatt)

30. september 2026

Datoer for studieregistrering

Først innsendt

16. juni 2026

Først innsendt som oppfylte QC-kriteriene

16. juni 2026

Først lagt ut (Faktiske)

22. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

30. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

25. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • TUF/EIRB/148/2025

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere